Processa Pharmaceuticals (PCSA) Cost of Revenue (2012 - 2015)
Processa Pharmaceuticals' Cost of Revenue came in at $58,292 for Q4 2015, compared with -$37,788 a year earlier and up 36.8% from the prior quarter.
Analysis
Processa Pharmaceuticals (PCSA) Cost of Revenue (2012 - 2015) Analysis & Trends
For FY2015, Processa Pharmaceuticals' Cost of Revenue was $125,876, up 88.3% from FY2014.
- Cost of Revenue carries a three-year compound annual growth rate of -1.9% (FY2012 to FY2015).
- Going back by year, Cost of Revenue was $66,833 in FY2014 (-64.5%), $188,002 in FY2013 (+41.1%) and $133,255 in FY2012.
- The Q4 2015 figure represents the highest quarterly Cost of Revenue since Q2 2014.
- Year-over-year, Cost of Revenue increased in three of the last six quarters, with growth averaging 13.0%.
- The fastest year-over-year change in Cost of Revenue over five years came in Q1 2015 (growth of 173.2%), and the weakest in Q2 2015 (a decline of 84.3%).
- Business Quant data shows PCSA's Cost of Revenue at $42,618 (Q3 2015), $11,007 (Q2 2015) and $24,966 (Q1 2015) in the three quarters before Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Processa Pharmaceuticals | 5.06 Mn | -8.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 58,292.00 |
| Sep 30, 2015 | 42,618.00 |
| Jun 30, 2015 | 11,007.00 |
| Mar 31, 2015 | 24,966.00 |
| Dec 31, 2014 | -37,788.00 |
| Sep 30, 2014 | 25,289.00 |
| Jun 30, 2014 | 70,192.00 |
| Mar 31, 2014 | 9,140.00 |
| Dec 31, 2013 | 33,902.00 |
| Sep 30, 2013 | 80,450.00 |
| Jun 30, 2013 | 61,525.00 |
| Mar 31, 2013 | 12,125.00 |
| Dec 31, 2012 | 33,106.00 |
| Sep 30, 2012 | 33,916.00 |
| Jun 30, 2012 | 53,828.00 |
API Access
Processa Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PCSA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "PCSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PCSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();